Back to Search
Start Over
Heart Rate Lowering for Coronary CTA with Ivabradine in End-Stage Liver Disease.
Heart Rate Lowering for Coronary CTA with Ivabradine in End-Stage Liver Disease.
- Source :
-
Radiology. Cardiothoracic imaging [Radiol Cardiothorac Imaging] 2024 Jun; Vol. 6 (3), pp. e230402. - Publication Year :
- 2024
- Subjects :
- Humans
Male
Middle Aged
Computed Tomography Angiography
Female
Coronary Artery Disease drug therapy
Coronary Artery Disease diagnostic imaging
Cardiovascular Agents therapeutic use
Cardiovascular Agents pharmacology
Benzazepines therapeutic use
Benzazepines pharmacology
Aged
Ivabradine therapeutic use
Ivabradine pharmacology
Heart Rate drug effects
End Stage Liver Disease drug therapy
Coronary Angiography
Subjects
Details
- Language :
- English
- ISSN :
- 2638-6135
- Volume :
- 6
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Radiology. Cardiothoracic imaging
- Publication Type :
- Academic Journal
- Accession number :
- 38814188
- Full Text :
- https://doi.org/10.1148/ryct.230402